null

null

null

null

null

null

null

null

null

null

null

null

null

null

null

null

null

null

0.26x Total Debt / Equity (Conservative)

Moderate exposure; ~$200M term loan at variable rates, 200bps rate rise adds ~$4M annual interest cost, compressing thin margins further

Low intensity; China and India supply >60% of global API inputs, creating concentration risk.

Not applicable; PACE model relies on domestic healthcare staffing and CMS reimbursement, no significant geopolitical chokepoints

null

Purely domestic US operator across CO, CA, NM, VA, PA, OH, FL; zero sovereign currency devaluation exposure

Low intensity; commodities: Active Pharmaceutical Ingredients, Rare Earth Elements, Natural Gas (energy), Plastics/Resins, Ethanol, Packaging Materials; geopolitical: China and India supply >60% of global API inputs, creating concentration risk.

CMS/Medicaid capitation represents ~100% of revenue; single-payer government dependency far exceeds 30% threshold — existential lock-in

Cloud disruption risk is low-moderate; core operations run on EHR platforms (PointClickCare/similar); 30-day termination would disrupt clinical workflows but workarounds exist within weeks

Capitated managed care provider; revenue is per-member-per-month government reimbursement, not SaaS or product-based

Moderate API coupling to EHR and care-coordination platforms; switching costs manageable but migration would require 6-12 months and CMS compliance re-validation

Fails Howey Test; revenue model is fee-for-service capitation from government payers, not an investment contract — negligible securities law risk

Very High

HIPAA is primary compliance framework; CCPA exposure moderate given CA operations; GDPR not applicable; PHI breach risk is the dominant regulatory concern

Low antitrust risk; PACE program market share is minimal nationally; serves niche frail-elderly population with limited competitive overlap

Very High burden; regimes: FDA, CMS, HHS, HIPAA, EMA, OIG; Drug pricing legislation and approval delays directly compress revenue visibility.

~95%+ recurring; monthly capitation payments from Medicare/Medicaid per enrolled member — highly predictable but volume-dependent on enrollment growth

Per-member-per-month capitation from CMS and state Medicaid agencies; revenue scales directly with enrolled participant headcount

Pricing set by CMS actuarial rates; InnovAge has no independent pricing power — rate risk is entirely regulatory and actuarial, not market-driven

1/10; rates are government-mandated capitation benchmarks; company cannot raise prices unilaterally under any market condition

18.0% Gross Margin (Thin (<20%))

No free-rider problem; enrolled participants are locked into PACE as their sole Medicare/Medicaid provider — voluntary disenrollment is rare but forced disenrollment risk exists

Revenue growth is highly headcount-linear; each new PACE center requires proportional clinical, care, and administrative staff — limited operating leverage

High marginal cost; new center openings require $5-10M+ capex plus 2-3 years to reach breakeven enrollment density — sublinear scale benefits are minimal

Not a franchise model; however, CMS enrollment freeze risk is severe — InnovAge faced CMS sanctions in 2022, demonstrating acute regulatory compliance drift exposure

At 10x scale, CAC would rise as addressable PACE-eligible population in dense geographies is finite; community outreach cost per enrolled member estimated $3,000-$6,000

No meaningful network effects; PACE is a direct-care model — adding participants does not improve value for existing participants

AI displacement risk is low near-term; hands-on personal care and medical management of frail elderly cannot be automated; AI may improve care coordination efficiency modestly

Tier 1 recession-resistant; Medicare/Medicaid reimbursement is government-funded and counter-cyclical — enrollment may increase in downturns as families seek subsidized elder care

Dual-eligible (Medicare + Medicaid) frail elderly adults aged 55+, requiring nursing-home-level care, predominantly low-income

CMS and state Medicaid agencies are the true economic customers; participant concentration risk is low but payer concentration risk is near-total

["11-0000 Management Occupations", "13-0000 Business and Financial Operations Occupations", "15-0000 Computer and Mathematical Occupations", "19-0000 Life, Physical, and Social Science Occupations", "21-0000 Community and Social Service Occupations", "23-0000 Legal Occupations", "29-0000 Healthcare Practitioners and Technical Occupations", "31-0000 Healthcare Support Occupations", "41-0000 Sales and Related Occupations", "43-0000 Office and Administrative Support Occupations", "51-0000 Production Occupations"]

0.32 (HIL — ~32% of characteristic roles agent-automatable)

0.7% CapEx / Revenue (Low-CapEx Asset-Light)

0001834376

INNV